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Synthetic Methods
Spirobicyclic and Tetracyclic Pyrazolidinones: Syntheses and
Properties
Fabien Perez,[a] Thibault Leveille,[a] Mathilde Bertolotti,[a] Jean Rodriguez,*[a] and
Yoann Coquerel*[a]
Dedicated to the memory of Professor Dr. Dieter Enders
Abstract: The stereoselective syntheses of spirobicyclic and
tetracyclic pyrazolidinones are reported based on a (3+2) annu-
lation between hydrazones and α-oxoketenes. Some of these
conformationally constrained molecules were resolved as enan-
Introduction
The use of small chiral and enantiopure organic molecules mim-
icking the activity of enzymes in accelerating enantioselective
organic chemical transformations is now referred to as enantio-
selective organocatalysis.[1] For instance, some organocatalysts
embedding a basic nitrogen atom are amenable to the activa-
tion of enals through the temporary catalytic formation of the
corresponding iminium ions to trigger, among others, Michael
additions and/or Diels–Alder cycloadditions.[2] Most often, the
iminium activation of enals has been found efficient with the
so-called Hayashi-Jørgensen and/or MacMillan's catalysts (Fig-
ure 1a),[2a–2d] which usually induced good enantioselectivity.
Despite their broad applicability, these catalysts are not ideal
with somewhat improvable stereoselectivities (typically 90–
95 % ee, rarely >98 % ee) and kinetics (typically 10 mol-% cata-
lyst loading for hours to days). Some alternative catalysts have
been proposed in order to overcome these limitations, notably
based on the hydrazide moiety (Figure 1b).[3] Herein, we report
modular stereoselective syntheses of spirobicyclic and tetracy-
clic pyrazolidinones of type 1–3 in a few steps from readily
available chemicals (Figure 1c), as well as the evaluation of their
properties as catalysts for the iminium activation of enals in a
model Diels–Alder cycloaddition.
[a] Aix Marseille Université,
CNRS, Centrale Marseille, ISM2, 13397 Marseille, France
E-mail: jean.rodriguez@univ-amu.fr
yoann.coquerel@univ-amu.fr
http://ism2.univ-amu.fr/en-gb/user/2207 (JR)
http://ism2.univ-amu.fr/en-gb/user/2204 (YC)
Supporting information and ORCID(s) from the author(s) for this article are
available on the WWW under https://doi.org/10.1002/ejoc.201900989.
Eur. J. Org. Chem. 2019, 6034–6043 © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim6034
tiopure materials by HPLC techniques and evaluated as amino-
catalysts for iminium activation in a model Diels–Alder cyclo-
addition.
Figure 1. Aminocatalysts for the enantioselective iminium activation of enals
and highlights of the present work.
Results and Discussion
We have earlier shown that α-oxoketenes, generated in situ by
a microwave-assisted Wolff rearrangement of 2-diazo-1,3-di-
carbonyl compounds,[4] are effective dipolarophiles in their re-
actions with azomethine imines in three-component processes,
which allowed the expeditious stereoselective syntheses of
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some spirobicyclic pyrazolidinones such as 2.[5] Originally, the
required hydrazone intermediates, which upon heating un-
dergo a 1,2-proton shift to give the corresponding reactive azo-
methine imines, were prepared in situ from carbonyl com-
pounds 4 and hydrazines 5 in the presence of the required
diazo compounds (three-component reaction). The formation
of the hydrazones from the corresponding carbonyl com-
pounds and hydrazines is accompanied by the formation of an
equimolar amount of water, and the latter can concurrently re-
act with α-oxoketenes to give the corresponding unstable "-
ketocarboxylic acids. For the complementary work herein, and
in the interest of efficiency, we have modified the original multi-
component procedure for a consecutive protocol allowing for
the elimination of undesired water after the formation of the
hydrazone intermediates. In practice, as an illustrative example,
a 1:1 mixture of benzaldehyde (4a) and phenyl hydrazine (5a)
in anhydrous toluene was irradiated with microwaves at 140 °C
for 5 minutes, cooled down to 55 °C, concentrated and dried in
vacuo. To the resulting material was added 2-diazo-1,3-cyclo-
hexanedione and anhydrous toluene, and the mixture was irra-
diated with microwaves at 140 °C for 10 additional minutes,
which afforded after purification 86 % yield of the expected
spiro product 2a and a trace amount of the uncyclized acyl-
hydrazone 6a (Table 1, entry 1). In comparison, only 57 % yield
was obtained for 2a using the multicomponent protocol.[5] Us-
ing this method, we attempted the syntheses of the representa-
Table 1. Synthesis of spirobicyclic pyrazolidinones 2.[a]
Entry Conditions Product R1, R2 Yield Yield of
of 2[b] 6[b]
1 140 °C, 10 min 2a, 6a: R1 = Ph, R2 = Ph 86 % <3 %[c]
2 140 °C, 10 min 2b, 6b: R1 = Me, R2 = Ph 49 % 45 %
3 140 °C, 10 min 2c, 6c: R1 = Ph, R2 = 4-NO2-C6H4 90 % <3 %[c]
4 140 °C, 10 min 2d, 6d: R1 = Me, R2 = 4-NO2-C6H4 5 % 89 %
5 200 °C, 30 min 2d, 6d: R1 = Me, R2 = 4-NO2-C6H4 56 % 19 %
6 180 °C, 20 min 2e, 6e: R1 = Ph, R2 = 4-OMe-C6H4 90 % <3 %[c]
7 170 °C, 30 min 2f, 6f: R1 = Me, R2 = 4-OMe-C6H4 42 % 39 %
8 170 °C, 45 min 2g, 6g: R1 = Me, R2 = 2-Me-C6H4 43 % 39 %[c]
9 180 °C, 25 min 2h, 6h: R1 = Me, R2 = CO2Et 10 % 56 %
10 180 °C, 35 min 2i, 6i: R1 = Me, R2 = CO2Bn 23 % 65 %
11 180 °C, 35 min 2j, 6j: R1 = Me, R2 = Bn 75 % <3 %[c]
12 160 °C, 15 min 2k, 6k: R1 = tBu, R2 = Ph 48 % <3 %[c]
[a] All reactions were performed under microwave irradiation in sealed ves-
sels. [b] Yields for the isolated product after purification unless otherwise
noted. [c] Estimated by 1H NMR analysis of the crude reaction mixture.
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tive spirobicyclic pyrazolidinones 2b–k. While reactions with
phenyl and tert-butyl hydrazines (5a and 5c, respectively) pro-
ceeded without event (entries 1, 3 and 12), the reactions with
methyl hydrazine (5b) were complicated by the formation of
the uncyclized acylhydrazones 6 in various proportions, for-
mally resulting from the simple nucleophilic addition of the in-
termediate hydrazone to the intermediate α-oxoketene. For in-
stance, only 5 % of 2d could be obtained together with 89 %
of 6d from a reaction performed at 140 °C for 10 min (entry 4).
However, increasing the reaction temperature to 200 °C for
30 min allowed obtaining 2d as the major product in 56 % yield
(entry 5). In a separate experiment, the uncyclized acylhydraz-
one 6h could be converted into its spirobicyclic pyrazolidinone
isomer 2h in 75 % yield by heating at 190 °C for 3 hours, show-
ing that 6h is the kinetic isomer and 2h the thermodynamic
one. Calculations of the free Gibbs energies of 6h and 2h by
DFT methods indicated that 2h is indeed stabilized by ca.
37.4 kJ mol–1 relative to 6h (see the Supporting Information).
The syntheses of derivatives 3 and 1 from 2 were devised
through the intermediacy of the corresponding triflyl enol
ethers 8 using catalytic palladium(0) chemistry. Thus, some se-
lected spirobicyclic pyrazolidinones 2 were protected as the
corresponding methyl or benzyl carbamates 7, which were then
converted into the desired triflyl enol ethers 8 under standard
conditions (Scheme 1). The relatively lower yields observed for
the formation of the corresponding triflyl enol ethers 8hBn and
8iBn from ketones 7hBn and 7iBn having R2 ester substituents
are probably due to the presence of a competing enolizable
position in these substrates.
Scheme 1. Generation of triflyl enol ethers 8.
The vinyl triflates 8hBn, 8iBn, and 8jBn were then subjected
to palladium-catalyzed reduction conditions using some
ammonium formate as the source of hydride, which afforded
the expected reduced products 9hBn, 9iBn and 9jBn, respec-
tively (Scheme 2). Treatment of 9hBn and 9jBn with hydrogen
gas in the presence of catalytic Pd/C led to the concomitant
hydrogenation of the double bond and cleavage of the benzyl
carbamate to give the spirobicyclic pyrazolidinones 3h and 3j,
respectively. Significantly, 3j slowly oxidized to the correspond-
ing spirobicyclic acylhydrazone when exposed to air or non-
degassed solvents (a reaction similar to 3b→ 12 in Scheme 3).
The scenario was found different with the vinyl triflates 8 hav-
ing an aromatic R2 group. Indeed, the triflate and the aryl R2
groups are in the same region of space for stereochemical rea-
sons, and some competing palladium-catalyzed cyclization may
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occur through activation of the aromatic C–H bond at C2.[6] In
practice, only C–H activation products were observed, even in
the presence of formic acid, and excellent yields of the tetracy-
clic compounds 10 were achieved (Scheme 2). Methanolysis of
the methyl carbamate 10aMe with LiOH/MeOH was found slow
and moderately selective, affording a modest 39 % yield of the
tetracyclic hydrazide 10a. The concomitant diastereoselective
hydrogenation/benzyl carbamate cleavage of 10fBn afforded
the tetracyclic pyrazolidinone 1f. The structures of 10a and the
trifluoromethylsulfonate salt 1f·CF3SO3H were elucidated by
monocrystal X-ray diffraction techniques, confirming the syn-
theses outcomes (Figure 2).[7]
Scheme 2. Syntheses of the spirobicyclic pyrazolidinones 3h,j and the tetra-
cyclic pyrazolidinones 10a, 1f.
Scheme 3. Synthesis of the spirobicyclic pyrazolidinone 3b.
Figure 2. 3D representations of 10aMe (left) and 1f·CF3SO3H (right) obtained
by monocrystal X-ray diffraction analyses. Ellipsoids are draw at the 50 %
probability level and H atoms are draw as fixed-size spheres of 0.15 Å ra-
dius.[7]
An alternative synthetic approach was devised for the spi-
robicyclic pyrazolidinone 3b not available by the above
sequence (Scheme 3). Cyclopentane 11, readily prepared by
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double C-alkylation of the corresponding !-ketoester with
1,4-dibromobutane,[8] was treated with methyl hydrazine to
give acylhydrazone 12, the hydrogenation of which afforded
pyrazolidinone 3b. Like its analog 3j, pyrazolidinone 3b was
found somewhat unstable in the presence of oxygen and slowly
oxidized back to the acylhydrazone 12.
A motivation for this synthetic work was the identification of
a competent catalyst for iminium activation in this series. Our
efforts in this direction are summarized below. It was rapidly
found that !-ketopyrazolidinones 2 were not suitable. For in-
stance, 2d did not promote the Diels–Alder cycloaddition be-
tween cinnamaldehyde (13) and cyclopentadiene (14) in the
absence of an acidic co-catalyst, while it was rapidly converted
into the ring-opened acylhydrazone 6d in the presence of tri-
fluoroacetic acid. We focused our efforts on pyrazolidinones 3h,
3j, 3b and 1f. The stoichiometric formation of the iminium ion
derived from hydrazide 3h and cinnamaldehyde (13) was quan-
titatively evaluated in the presence of weak to super acids (Fig-
ure 3). In all cases equilibrium was reached after a few hours at
25 °C. Benzoic acid, the weakest, left the substrates unchanged,
and trifluoromethanesulfonic acid, the strongest, promoted a
nearly quantitative formation of the (E)-configured iminium ion
exclusively, as determined by NMR (the iminium ion derived
from hydrazide 3j and 13 was also found (E)-configured, see the
Supporting Information) and in full agreement with previous
observations.[3a,3c]
Figure 3. Formation of the iminium ion derived from pyrazolidinone 3h and
cinnamaldehyde (13) at 25 °C in d3-nitromethane. Conversions were deter-
mined by 1H NMR.
The enantiomers of pyrazolidinones 3h, 3j and 3b were re-
solved by semi-preparative HPLC on chiral stationary phases
(see the Supporting Information) and their catalytic properties
evaluated, together with those of racemic 1f, in the model
enantioselective (not for 1f ) Diels–Alder cycloaddition between
cinnamaldehyde (13) and cyclopentadiene (14). Our best, but
rather modest, results are summarized in Scheme 4. Pyrazol-
idinone (+)-3h promoted the reaction at an acceptable rate but
with virtually no stereoselectivity, while pyrazolidinone (+)-3j
was found to induce some enantioselectivity, 71 % ee at best
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for the exo minor diastereomer, but at a slower rate. Pyrazol-
idinone (+)-3b afforded preferentially the exo diastereomer in
54 % ee, while rac-1f predominantly led to the endo diastereo-
mer. The better rate observed with (+)-3h was attributed to the
presence of the electron-withdrawing substituent at position
5.[9]
Scheme 4. Evaluation of the organocatalytic properties of 3h, 3j, 3b and 1f
for the enantioselective (not for 1f ) iminium activation of cinnamaldehyde
(13) in its Diels–Alder cycloaddition with cyclopentadiene (14). The absolute
configurations of (+)-3h was confirmed as (R) by VCD techniques, the de-
picted absolute configurations for (+)-3j and (+)-3b are arbitrary and unveri-
fied.
The absolute configuration of (+)-3h was unambiguously as-
signed as (R) by vibrational circular dichroism spectroscopy (see
the Supporting Information). The absolute configurations of the
major enantiomers of the cycloadducts obtained with (+)-3h
and (+)-3b were determined as (S) at the carbon atom bearing
the aldehyde by comparison with the cycloadducts obtained
with the MacMillan's catalysts of known enantio-induction,[2a]
and pyrazolidinone (+)-3j induced opposite enantioselectivity.
Overall, these stereochemical considerations are fully consistent
with an approach of the cyclopentadiene (14) from the α face
of the (E)-configured iminium ions derived from (+)-3h, in full
agreement with earlier studies.
Conclusions
In summary, the (3+2) annulation reaction between α-oxo-
ketenes and hydrazones was confirmed as a powerful synthetic
approach to diverse, structurally complex, conformationally
constrained, and yet stereodefined polycyclic pyrazolidinones
including spirobicyclic, bis-spirotricyclic (previous work[5]), and
tetracyclic derivatives obtained in just a few steps from simple
chemicals. Notably, palladium-catalyzed cyclizations allowed
the efficient construction of tetracyclic backbones through aro-
matic C–H bond activation. The catalytic properties of some
selected pyrazolidinones were evaluated for the enantioselec-
tive iminium activation of cinnamaldehyde (13) in a model ar-
chetypal Diels–Alder cycloaddition without significant improve-
ment when compared to known systems.
Experimental Section
General Procedure for Pyrazolidinones 2 and Acylhydrazones 6:
A solution of hydrazine and aldehyde in anhydrous toluene (ca.
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0.4 M) under an argon atmosphere in a sealed tube containing a
Teflon coated magnetic stirring bar was irradiated at 140 °C for 5
minutes, cooled down to 55 °C by airflow and concentrated in
vacuo. To the resulting material placed under argon atmosphere
was added 2-diazo-cyclohexan-1,3-dione and anhydrous toluene
(ca. 0.4 M), and the reaction mixture was irradiated with microwaves
under the conditions mentioned in Table 1. The resulting mixture
was cooled down to 55 °C by airflow, concentrated in vacuo and
directly purified by flash chromatography. PE refers to petroleum
ether (bp 40–60 °C) and melting points are reported for amorphous
material unless specified otherwise.
Pyrazolidinone 2a: Following the general procedure with benz-
aldehyde (366 µL, 3.62 mmol), phenylhydrazine (359 µL, 3.62 mmol)
and 2-diazo-1,3-cyclohexanedione (500 mg, 3.62 mmol) in 9 mL of
anhydrous toluene at 140 °C for 10 min, and using EtOAc/PE, 1:9 as
eluent for the flash chromatography, 2a was obtained as a white
solid (953 mg, 86 %). The 1H NMR analysis of the crude material
showed that no more than 3 % of acylhydrazone 6a (not isolated)
was formed. Rf (EtOAc/PE, 1:9) = 0.36. 1H NMR (300 MHz, δ ppm/
CDCl3): 7.92 (dd, J = 1.2, 8.8 Hz, 2H), 7.44–7.31 (m, 7H), 7.15 (pseudo
t, J = 7.4 Hz, 1H), 5.60 (d, J = 12.8 Hz, 1H), 4.66 (d, J = 12.9 Hz, 1H),
2.73 (ddd, J = 13.5, 8.2, 8.2 Hz, 1H), 2.27–2.09 (m, 2H), 2.07–1.95 (m,
1H), 1.89–1.75 (m, 1H), 1.64–1.47 (m, 1H). These data are in agree-
ment with previously reported data for this compound.[5]
Pyrazolidinone 2b and Acylhydrazone 6b: Following the general
procedure with benzaldehyde (92 µL, 0.90 mmol), methylhydrazine
(54 µL, 1.03 mmol) and 2-diazo-1,3-cyclohexanedione (125 mg,
0.90 mmol) in 3 mL of anhydrous toluene at 140 °C for 10 min, and
using AcOEt/PE, 4:6 as eluent for the flash chromatography, 6b and
2b were obtained, in that order, as a white solids (6b: 100 mg,
45 %; 2b:127 mg, 49 %). For 6b: Rf (AcOEt/PE, 4:6) = 0.60. Mp 109.4–
111.4 °C. HRMS (ESI+): [M + H]+ calcd. for C14H17N2O2+ 245.1285,
found 245.1287. 1H NMR (300 MHz, δ ppm/CDCl3): 7.74 (s, 1H), 7.65–
7.61 (m, 2H), 7.44–7.35 (m, 2H), 4.44 (dd, J = 9.7, 9.7 Hz, 1H), 3.42
(s, 3H), 2.45–2.33 (m, 4H), 2.28–2.13 (m, 1H), 2.04–1.84 (m, 1H). 13C
NMR (75 MHz, δ ppm/CDCl3): 214.0 (C), 171.6 (C), 140.0 (CH), 134.7
(C), 129.9 (CH), 128.9 (2CH), 127.3 (2CH), 53.1 (CH), 38.6 (CH2), 28.4
(CH3), 28.1 (CH2), 21.4 (CH2). For 2b: Rf (AcOEt/PE, 4:6) = 0.12. Mp
101.6–103.6 °C. HRMS (ESI+): [M + H]+ calcd. for C14H17N2O2+
245.1285, found 245.1287. 1H NMR (300 MHz, δ ppm/CDCl3): 7.39–
7.33 (m, 3H), 7.30–7.26 (m, 2H), 5.22 (d, J = 12.0 Hz, 1H), 4.52 (d, J =
12.0 Hz, 1H), 3.21 (s, 3H), 2.63 (ddd, J = 13.8, 8.2, 8.2 Hz, 1H), 2.21–
1.88 (m, 4H), 1.73 (ddd, J = 13.7, 8.7, 5.3 Hz, 1H), 1.49 (m, 1H). 13C
NMR (75 MHz, δ ppm/CDCl3): 216.2 (C), 171.1 (C), 133.4 (C), 129.3
(C), 129.1 (2CH), 127.5 (2CH), 70.7 (CH), 63.7 (C), 39.2 (CH2), 32.0
(CH3), 30.2 (CH2), 19.8 (CH2).
Pyrazolidinone 2c: Following the general procedure with p-nitro-
benzaldehyde (138 mg, 0.90 mmol), phenylhydrazine (91 µL,
0.90 mmol) and 2-diazo-1,3-cyclohexanedione (125 mg, 0.90 mmol)
in 3 mL of anhydrous toluene at 140 °C for 10 min, and using EtOAc/
PE, 3:7 as eluent for the flash chromatography, 2c was obtained as
a red solid (286 mg, 90 %). The 1H NMR analysis of the crude mate-
rial showed that no more than 3 % of acylhydrazone 6c (not iso-
lated) was formed. Rf (AcOEt/PE, 3:7) = 0.28. Mp: 157.4–159.4 °C.
HRMS (ESI+): [M + H]+ calcd. for C19H18N3O4+ 352.1292, found
352.1291. 1H NMR: (300 MHz, δ ppm/CDCl3): 8.26 (d, J = 8.7 Hz, 2H),
7.89 (d, J = 7.9 Hz, 2H), 7.54 (d, J = 8.7 Hz, 2H), 7.39 (dd, J = 7.9,
7.9 Hz, 2H), 7.17 (dd, J = 7.4. 7.4 Hz, 1H), 5.68 (d, J = 12.7 Hz, 1H),
4.80 (d, J = 12.7 Hz, 1H), 2.86–2.71 (m, 1H), 2.30 (ddd, J = 13.1, 7.7,
7.6 Hz, 1H), 2.22–2.08 (m, 2H), 1.95–1.80 (m, 1H), 1.71–1.56 (m, 1H).
13C NMR (300 MHz, δ ppm/CDCl3): 215.3 (C), 169.2 (C), 148.4 (C),
140.6 (C), 138.5 (C), 129.0 (2CH), 128.6 (2CH), 125.2 (CH), 124.2 (2CH),
118.8 (2CH), 68.4 (CH), 65.2 (C), 39.5 (CH2), 30.3 (CH2), 19.9 (CH2).
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Pyrazolidinone 2d and Acylhydrazone 6d: Following the general
procedure with p-nitro-benzaldehyde (138 mg, 0.90 mmol), methyl-
hydrazine (54 µL, 1.03 mmol) and 2-diazo-1,3-cyclohexanedione
(125 mg, 0.90 mmol) in 3 mL of anhydrous toluene at 140 °C for
10 min, and using AcOEt/PE, 3:7 then 4:6 as eluent for the flash
chromatography, 6d and 2d were obtained, in that order, as orange
and yellow solids, respectively, (6d: 222 mg, 89 %; 2d:12 mg, 5 %).
A similar reaction performed at 200 °C for 30 min afforded the same
products 6d and 2d in 19 % and 56 % yield, respectively. For 6d: Rf
(AcOEt/PE, 3:7) = 0.47. HRMS (ESI+): [M + H]+ calcd. for C14H16N3O4+
290.1135, found 290.1135. Mp 166.4–168.4 °C. 1H NMR (300 MHz,
δ ppm/C6D6): 7.85 (d, J = 8.8 Hz, 2H), 7.11 (d, J = 8.8 Hz, 2H), 6.75
(s, 1H), 4.31 (dd, J = 10.4, 8.8 Hz, 1H), 2.77 (s, 3H), 2.37 (dddd, J =
12.7, 10.4, 10.4, 6.9 Hz, 1H), 1.99–1.83 (m, 3H), 1.74–1.59 (m, 1H),
1.42–1.25 (m, 1H). 13C NMR (75 MHz, δ ppm/CDCl3): 213.5 (C), 171.5
(C), 140.7 (C), 136.9 (CH), 127.7 (2CH), 124.2, (2CH), 110.1 (C), 52.8
(CH), 38.6 (CH2), 28.7 (CH3), 27.8 (CH2), 21.2 (CH2). For 2d: Rf (AcOEt/
CH2Cl2, 4:6) = 0.25. Mp 156.0–157.0 °C. HRMS (ESI+): [M + H]+ calcd.
for C14H16N3O4+ 290.1135, found 290.1137. 1H NMR (300 MHz, δ
ppm/CDCl3): 8.23 (d, J = 8.6 Hz, 2H), 7.48 (d, J = 8.6 Hz, 2H), 5.28
(d, J = 12.3 Hz, 1H), 4.66 (d, J = 12.3 Hz, 1H), 3.21 (s, 3H), 2.77–2.60
(m, 1H), 2.31–2.15 (m, 1H), 2.18–1.99 (m, 2H), 1.88–1.71 (m, 1H),
1.68–1.47 (m, 1H). 13C NMR (75 MHz, δ ppm/CDCl3): 215.6 (C), 170.2
(C), 148.3 (C), 140.9 (C), 128.5 (2CH), 124.1 (2CH), 69.2 (CH), 63.5 (C),
39.4 (CH2), 32.1 (CH2), 30.3 (CH3), 19.9 (CH2).
Pyrazolidinone 2e: Following the general procedure with p-meth-
oxy-benzaldehyde (440 µL, 3.62 mmol), phenylhydrazine (359 µL,
3.62 mmol) and 2-diazo-1,3-cyclohexanedione (500 mg, 3.62 mmol)
in 9 mL of anhydrous toluene at 180 °C for 20 min, and using EtOAc/
PE, 2:8 as eluent for the flash chromatography, 2e was obtained as
an orange solid (1095 mg, 90 %). The 1H NMR analysis of the crude
material showed that no more than 3 % of acylhydrazone 6e (not
isolated) was formed. Rf (EtOAc/PE, 2:8) = 0.19. Mp 160.9–162.9 °C.
HRMS (ESI+): [M + H]+ calcd. for C20H21N2O3+ 337.1547, found
337.1544. 1H NMR (300 MHz, δ ppm/CDCl3): 7.95–7.87 (m, 2H), 7.37
(dd, J = 8.7, 7.3 Hz, 2H), 7.28–7.24 (m, 2H), 7.19–7.10 (m, 1H), 6.91
(d, J = 8.7 Hz, 2H), 5.50 (d, J = 12.8 Hz, 1H), 4.60 (d, J = 12.7 Hz, 1H),
3.82 (s, 3H), 2.71 (ddd, J = 13.8, 8.1, 8.1 Hz, 1H), 2.29–1.94 (m, 3H),
1.90–1.77 (m, 1H), 1.64–1.49 (m, 1H). 13C NMR (75 MHz, δ ppm/
CDCl3): 216.0 (C), 170.1 (C), 160.3 (C), 138.9 (C), 128.9 (2CH), 128.8
(2CH), 125.1 (C), 124.8 (CH), 118.8 (2CH), 114.6 (2CH), 69.4 (CH), 65.5
(C), 55.4 (CH3), 39.4 (CH2), 30.3 (CH2), 19.8 (CH2).
Pyrazolidinone 2f and Acylhydrazone 6f: Following the general
procedure with p-methoxy-benzaldehyde (112 µL, 0.90 mmol),
methylhydrazine (54 µL, 1.03 mmol) and 2-diazo-1,3-cyclohexanedi-
one (125 mg, 0.90 mmol) in 3 mL of anhydrous toluene at 170 °C
for 30 min, and using AcOEt/PE, 4:6 as eluent for the flash chroma-
tography, 6f and 2f were obtained, in that order, as a colorless oil
and a white solid, respectively, (6f: 97 mg, 39 %; 2f:104 mg, 42 %).
For 6f: Rf (AcOEt/PE, 4:6) = 0.30. HRMS (ESI+): [M + H]+ calcd. for
C15H19N2O3+ 275.1390, found 275.1389. 1H NMR (300 MHz, δ ppm/
CDCl3): 7.68 (s, 1H), 7.54 (d, J = 8.5 Hz, 2H), 6.90 (d, J = 8.5 Hz, 2H),
4.39 (dd, J = 9.6. 9.6 Hz, 1H), 3.81 (s, 3H), 3.36 (s, 3H), 2.42–2.30 (m,
4H), 2.25–2.10 (m, 1H), 2.03–1.80 (m, 1H). 13C NMR (75 MHz, δ ppm/
CDCl3): 214.1 (C), 171.4 (C), 161.1 (C), 139.8 (CH), 128.7 (2CH), 127.4
(C), 114.3 (2CH), 55.4 (CH3), 53.1 (CH), 38.5 (CH2), 28.2 (CH3), 28.1
(CH2), 21.3 (CH2). For 2f: Rf (AcOEt/PE, 4:6) = 0.10. HRMS (ESI+):
[M + H]+ calcd. for C15H19N2O3+ 275.1390, found 275.1390. Mp
131.4–133.4 °C. 1H NMR (300 MHz, δ ppm/CDCl3): 7.20 (d, J = 8.7 Hz,
2H), 6.87 (d, J = 8.7 Hz, 2H), 5.14 (s, 1H), 4.45 (s, 1H), 3.80 (s, 3H),
3.20 (s, 3H), 2.61 (d, J = 3.1 Hz, 1H), 2.13 (d, J = 1.5 Hz, 1H), 1.97 (s,
2H), 1.79 (s, 1H), 1.50 (s, 1H). 13C NMR (75 MHz, δ ppm/CDCl3): 216.4
(C), 171.0 (C), 160.2 (C), 128.7 (2CH), 125.3 (C), 114.4 (2CH), 70.3
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(CH), 63.7 (C), 55.4 (CH3), 39.2 (CH2), 31.9 (CH3), 30.2 (CH2), 19.8
(CH2).
Pyrazolidinone 2g: Following the general procedure with 2-
methyl-benzaldehyde (420 µL, 3.62 mmol), methylhydrazine
(213 µL, 4.07 mmol) and 2-diazo-1,3-cyclohexanedione (500 mg,
3.62 mmol) in 12 mL of anhydrous toluene at 170 °C for 45 min,
and using EtOAc/PE, 4:6 as eluent for the flash chromatography, 2g
was obtained as a yellow solid (643 mg, 43 %). The 1H NMR analysis
of the crude material evidenced the formation of ca. 39 % of acyl-
hydrazone 6g (not isolated). Rf (AcOEt/PE, 4:6) = 0.12. Mp 164.6–
166.6 °C. HRMS (ESI+): [M + H]+ calcd. for C15H19N2O2+ 259.1441,
found 259.1440. 1H NMR (300 MHz, δ ppm/CDCl3): 7.29–7.18 (m,
4H), 5.22 (d, J = 12.0 Hz, 1H), 4.52 (d, J = 12.0 Hz, 1H), 3.18 (s, 3 H),
2.70–2.56 (m, 1H), 2.51 (s, 3H) 2.26–1.93 (m, 3H), 1.86 (dddd, J =
18.7, 8.8, 4.4, 1.6 Hz, 1H), 1.51–1.39 (m, 1H). 13C NMR (75 MHz, δ
ppm/CDCl3): 216.2 (C), 171.0 (C), 133.5 (C), 129.3 (CH), 129.1 (2CH),
127.5 (2CH), 70.7 (CH), 63.8 (C), 39.2 (CH2), 32.0 (CH3), 30.2 (CH2),
19.8 (CH2).
Pyrazolidinone 2h and Acylhydrazone 6h: Following the general
procedure with ethyl glyoxalate (50 % in toluene, 716 µL,
3.62 mmol), methylhydrazine (213 µL, 4.07 mmol) and 2-diazo-1,3-
cyclohexanedione (500 mg, 3.62 mmol) in 9 mL of anhydrous tolu-
ene at 180 °C for 25 min, and using AcOEt/PE, 4:6 as eluent for the
flash chromatography, 6h and 2h were obtained, in that order, as
white solids (6h: 490 mg, 56 %; 2h:87 mg, 10 %). For 6h: Rf (EtOAc/
PE, 4:6) = 0.54. Mp 68.3–70.3 °C. HRMS (ESI+): [M + H]+ calcd. for
C11H17N2O4+ 241.1183, found 241.1182. 1H NMR (400 MHz, δ ppm/
CDCl3): 7.00 (s, 1H) 4.30 (q, J = 7.1 Hz, 2H), 3.97 (dd, J = 9.8, 9.8 Hz,
1H), 3.29 (s, 3H), 2.70 (ddd, J = 19.4, 9.8, 9.8 Hz, 1H), 2.35 (m, 3H),
2.21 (s, 1H) 1.99–1.80 (m, 1H), 1.34 (t, J = 7.1 Hz, 3H). 13C NMR
(75 MHz, δ ppm/CDCl3): 213.3 (C), 172.3 (C), 162.7 (C), 129.2(CH),
61.4 (CH2), 54.5 (CH), 37.7 (CH2), 28.6 (CH3), 27.9 (CH2), 21.4 (CH2),
14.2 (CH3). For 2h: Rf (AcOEt/PE, 4:6) = 0.27. Mp 98.4–100.4 °C. HRMS
(ESI+): [M + H]+ calcd. for C11H17N2O4+ 241.1183, found 241.1183.
1H NMR (300 MHz, δ ppm/CDCl3): 5.13 (d, J = 11.3 Hz, 1H), 4.24–
4.10 (m, 3H), 3.04 (s, 3H), 2.62–2.48 (m, 1H), 2.42–2.10 (m, 4H), 2.15–
1.98 (m, 1H). 13C NMR (75 MHz, δ ppm/CDCl3): 215.5 (C), 168.8 (C),
168.0 (C), 65.1 (CH), 62.1 (CH2), 60.1 (C), 38.6 (CH2), 31.8 (CH2), 31.7
(CH3), 19.9 (CH2), 14.1 (CH3).
Pyrazolidinone 2i and Acylhydrazone 6i: Following the general
procedure with benzyl glyoxalate (188 mg, 1.14 mmol), methyl-
hydrazine (66 µL, 1.26 mmol) and 2-diazo-1,3-cyclohexanedione
(220 mg, 1.14 mmol) in 3 mL of anhydrous toluene at 180 °C for
35 min, and using AcOEt/PE, 4:6 as eluent for the flash chromatogra-
phy, 6i and 2i were obtained, in that order, as white solids (6i:
226 mg, 65 %; 2i:79 mg, 23 %). For 6i: Rf (EtOAc/PE, 4:6) = 0.65. Mp
107.5–108.5 °C. HRMS (ESI+): [M + H]+ calcd. for C16H19N2O4+
303.1339, found 303.1339. 1H NMR (300 MHz, δ ppm/CDCl3): 7.41–
7.35 (m, 5H), 7.03 (s, 1H), 5.33–5.22 (m, 2H), 3.95 (dd, J = 10.0,
10.0 Hz, 2H), 3.28 (s, 3H), 2.63–2.49 (m, 1H), 2.36–2.26 (m, 2H), 2.26–
2.17 (m, 1H), 2.16–2.04 (m, 1H), 1.91–1.73 (m, 1H). 13C NMR (75 MHz,
δ ppm/CDCl3): 213.1 (C), 172.3 (C), 162.4 (C), 135.2 (C), 128.7 (CH),
128.6 (2CH), 128.5 (CH), 128.4 (2CH), 67.1 (CH2), 54.5 (CH), 37.6 (CH2),
28.6 (CH3), 27.9 (CH2), 21.3 (CH2). The structure of 6i was further
ascertained by COSY and HSQC 2D NMR experiments. For 2i: Rf
(AcOEt/PE, 4:6) = 0.25. Mp 147.0–149.0 °C. HRMS (ESI+): [M + H]+
calcd. for C16H19N2O4+ 303.1339, found 303.1339. 1H NMR (300 MHz,
δ ppm/CDCl3): 7.31–7.37, (m, 5H), 5.25, (d, J = 11.6 Hz, 1H), 5.18, (d,
J = 11.0 Hz, 1H), 5.09 (d, J = 11.6 Hz, 1H), 4.19 (d, J = 11.0 Hz, 1H),
3.06 (s, 3H), 2.58–2.49 (m, 1H), 2.32–2.06 (m, 3H), 1.99–1.81 (m, 2H).
13C NMR (75 MHz, δ ppm/CDCl3): 215.3 (C), 168.8 (C), 167.9 (C),
134.5 (C), 129.0 (CH), 129.0 (2CH), 128.8 (2CH), 67.8 (CH2), 65.1 (CH)
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60.6 (C), 38.4 (CH2), 31.7 (CH3), 31.7 (CH2), 19.8 (CH2). The structure
of 2i was further ascertained by COSY, HSQC and HMBC 2D NMR
experiments.
Pyrazolidinone 2j: Following the general procedure with phen-
ylacetaldehyde (423 µL, 3.80 mmol), methylhydrazine (213 µL,
4.07 mmol) and 2-diazo-1,3-cyclohexanedione (500 mg, 3.62 mmol)
in 9 mL of anhydrous toluene at 180 °C for 35 min, and using EtOAc/
PE, 3:7 as eluent for the flash chromatography, 2j was obtained as
a colorless oil (700 mg, 75 %). The 1H NMR analysis of the crude
material showed that no more than 3 % of acylhydrazone 6j (not
isolated) was formed. Rf (AcOEt/PE, 3:7) = 0.14. HRMS (ESI+): [M +
H]+ calcd. for C15H19N2O2+ 259.1441, found 259.1440. 1H NMR
(300 MHz, δ ppm/CDCl3): 7.35–7.25 (m, 3H), 7.21–7.16 (m, 2H), 4.60
(d, J = 12.1 Hz, 1H), 3.79 (ddd, J = 12.1, 8.1, 6.8 Hz, 1H), 3.00–2.83
(m, 2H), 2.51–2.29 (m, 2H), 2.28–2.05 (m, 2H), 1.65–1.51 (m, 2H). 13C
NMR (75 MHz, δ ppm/CDCl3): 216.7 (C), 171.4 (C), 136.7 (C), 129.0
(2CH), 128.9 (2CH), 127.3 (CH), 66.7 (CH), 61.3 (C), 40.0 (CH2), 34.2
(CH2), 31.8 (CH3), 30.9 (CH2), 20.0 (CH2).
Pyrazolidinone 2k: A solution of tert-butylhydrazine hydrochloride
(541 mg, 4.34 mmol), potassium bicarbonate (750 mg, 5.43 mmol)
and benzaldehyde (366 µL, 3.62 mmol) in 9 mL anhydrous dichloro-
methane under an argon atmosphere in a sealed tube containing
a Teflon coated magnetic stirring bar was irradiated at 140 °C for
10 minutes, cooled down to 55 °C by airflow and concentrated in
vacuo. The resulting material was dissolved/suspended in 9 mL tol-
uene and filtered. The liquid phase was placed under argon atmos-
phere in a sealed tube containing a Teflon coated magnetic stirring
bar, 2-diazo-cyclohexan-1,3-dione (500 mg, 3.62 mmol) was added
and this mixture was irradiated at 160 °C for 15 min. The resulting
reaction mixture was cooled down to 55 °C by airflow, concentrated
and purify by flash chromatography using EtOAc/PE, 1:9 as eluent
to afford 2k as a white solid (500 mg, 48 %). The 1H NMR analysis
of the crude material showed that no more than 3 % of acyl-
hydrazone 6k (not isolated) was formed. Rf (AcOEt/PE, 1:9) = 0.30.
Mp 110.3–112.3 °C. HRMS (ESI+): [M + H]+ calcd. for C17H23N2O2+
calcd. 287.1754, found 287.1754. 1H NMR (400 MHz, δ ppm/CDCl3):
7.38–7.33 (m, 3H), 7.29–7.27 (m, 2H), 5.12 (d, J =11.0 Hz, 1H), 4.37
(d, J = 11.0 Hz, 1H), 2.66–2.53 (m, 1H), 2.18–2.06 (m, 1H), 2.04–1.87,
(m, 2H), 1.80–1.70, (m, 1H), 1.51, (s, 9H), 1.50–1.42 (m, 1H). 13C NMR
(101 MHz, δ ppm/CDCl3): 216.5 (C), 171.0 (C), 133.9 (C), 123.1 (CH),
129.03 (2CH), 127.5 (2CH), 70.5 (CH), 65.4 (C), 58.0 (C), 39.5 (CH2),
30.0 (CH2), 28.0 (3CH3), 19.8 (CH2).
General Procedure for Carbamates 7: To a solution of pyrazol-
idinone 2 (1 equiv.) in THF (ca. 0.1 M) was added slowly the appro-
priate chloroformate (1.2–2 equiv.) follow by a 2 M solution of so-
dium carbonate in water (2–3 equiv.). The resulting solution was
stirred at room temperature until full conversion (monitored by
TLC). The solution was diluted with brine and extracted 3 times
with dichloromethane. The organic layers were combined, dried
with anhydrous sodium sulfate, concentrated in vacuo and purified
by flash chromatography.
Carbamate 7aMe: Following the general procedure with 2b
(457 mg, 1.87 mmol), methylchloroformate (290 µL, 3.74 mmol) and
a 2 M solution of Na2CO3 (3.6 mL, 7.2 mmol) in 19 mL of THF for
1 h 45, and using EtOAc/PE, 2:8 as eluent for the flash chromatogra-
phy, 7aMe was obtained as a yellow solid (499 mg, 88 %). Rf (AcOEt/
PE, 2:8) = 0.21. Mp 140.9–141.5 °C. HRMS (ESI+): [M + H]+ calcd. for
C16H19N2O4+ 303.1339, found 303.1341. 1H NMR (300 MHz, δ ppm/
CDCl3): 7.40–7.25 (m, 3 H), 7.12–7.02 (m, 2H), 5.33 (s, 1H), 3.83 (s,
3H), 3.46 (s, 3H), 2.52–2.39 (m, 1H), 2.34–2.00 (m, 5H). 13C NMR
(75 MHz, δ ppm/CDCl3): 210.6 (C), 170.1 (C), 158.2 (C), 136.0 (C),
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128.9 (2CH), 128.6 (CH), 126.2 (2CH), 71.0 (CH), 63.2 (C), 54.1 (CH3),
38.5 (CH2), 35.2 (CH2), 34.3 (CH3), 20.0 (CH2).
Carbamate 7aBn: Following the general procedure with 2b
(1405 mg, 5.75 mmol), benzylchloroformate (1.60 mL, 11.5 mmol)
and a 2 M solution of Na2CO3 (8.6 mL, 17.2 mmol) in 60 mL of THF
for 4 h, and using EtOAc/PE, 2:8 as eluent for the flash chromatogra-
phy, 7aBn was obtained as a white solid (1695 mg, 78 %). Rf (AcOEt/
PE, 2:8) = 0.15. Mp 101.1–102.1 °C. HRMS (ESI+): [M + H]+ calcd. for
C22H23N2O4+ 379.1652, found 379.1654. 1H NMR (300 MHz, δ ppm/
CDCl3): 7.41–7.28 (m, 8H), 7.07 (dd, J = 7.6, 2.0 Hz, 2H), 5.32 (s, 1H),
5.28 (d, J = 12.2 Hz, 1H), 5.17 (d, J = 12.2 Hz, 1H), 3.45 (s, 3H), 2.53–
2.29 (m, 1H), 2.27–1.93 (m, 5H). 13C NMR (75 MHz, δ ppm/CDCl3):
210.8 (C), 170.1 (C), 157.7 (C), 136.0 (C), 135.2 (C), 128.9 (2CH), 128.8
(2CH), 128.8 (CH), 128.7 (CH), 128.3 (2CH), 126.4 (2CH), 71.0 (CH),
68.9 (CH2), 63.2 (C), 38.5 (CH2), 34.9 (CH2), 34.5 (CH3), 19.9 (CH2).
Carbamate 7dMe: Following the general procedure with 2d
(527 mg, 1.82 mmol), methylchloroformate (170 µL, 2.19 mmol) and
a 2 M solution of Na2CO3 (1.8 mL, 3.6 mmol) in 19 mL of THF for
4 h, and using EtOAc/CH2Cl2, 4:6 as eluent for the flash chromatog-
raphy, 7dMe was obtained as a yellow solid (632 mg, 99 %). Rf
(AcOEt/DCM, 4:6) = 0.63. Mp 186.8–188.8 °C. HRMS (ESI+): [M + H]+
calcd. for C16H18N3O6+ 348.1190, found 348.1190. 1H NMR (300 MHz,
δ ppm/CDCl3): 8.20 (d, J = 9.0 Hz, 2 H), 7.25 (d, J = 9.0 Hz, 2 H), 5.39
(s, 1 H), 3.85 (s, 3 H), 3.47 (s, 3 H), 2.59–2.47 (m, 1H), 2.39–2.20 (m,
3H), 2.18–2.01 (m, 2H). 13C NMR (75 MHz, δ ppm/CDCl3): 211.0 (C),
169.4 (C), 158.0 (C), 147.8 (C), 143.2 (C), 127.4 (2CH), 124.0 (2CH),
70.0 (CH), 62.9 (C), 54.4 (CH3), 38.9 (CH2), 35.4 (CH2), 34.3 (CH3), 20.1
(CH2).
Carbamate 7fBn: Following the general procedure with 2f (550 mg,
2.00 mmol), benzylchloroformate (440 µL, 3.10 mmol) and a 2 M
solution of Na2CO3 (2.5 mL, 5.0 mmol) in 20 mL of THF for 4 h, and
using EtOAc/PE, 2:8 as eluent for the flash chromatography, 7fBn
was obtained as a colorless oil (674 mg, 82 %). Rf (AcOEt/PE, 2:8) =
0.23. HRMS (ESI+): [M + H]+ calcd. for C23H25N2O5+ 409.1758, found
409.1764. 1H NMR (300 MHz, δ ppm/CDCl3): 7.38–7.33 (m, 3H), 7.31–
7.25 (m, 2H), 7.01 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 5.27
(d, J = 11.6 Hz, 1H), 5.25 (s, 1H), 5.16 (d, J = 11.6 Hz, 1H), 3.78 (s,
3H), 3.43 (s, 3H), 2.38 (m, 1H), 2.12 (m, 4H), 1.97 (m, 1H). 13C NMR
(75 MHz, δ ppm/CDCl3): 210.8 (C), 170.3 (C), 159.8 (C), 157.7 (C),
135.3 (C), 128.8 (2CH), 128.8 (CH), 128.2 (2CH), 128.2 (C), 127.8 (2CH),
114.3 (2CH), 70.7 (CH), 68.9 (CH2), 63.1 (C), 55.4 (CH3), 38.4 (CH2),
34.9 (CH2), 34.6 (CH3), 19.9 (CH2).
Carbamate 7gMe: Following the general procedure with 2g
(502 mg, 1.94 mmol), methylchloroformate (180 µL, 2.32 mmol) and
a 2 M solution of Na2CO3 (1.9 mL, 3.8 mmol) in 19 mL of THF for
2 h, and using EtOAc/PE, 4:6 as eluent for the flash chromatography,
7gMe was obtained as a white solid (607 mg, 99 %). Rf (AcOEt/PE,
4:6) = 0.25. Mp 157.3–159.0 °C. HRMS (ESI+): [M + H]+ calcd. for
C17H21N2O4+ 317.1496, found 317.1496. 1H NMR (300 MHz, δ ppm/
CDCl3): 7.25–7.17 (m, 2H), 7.10 (ddd, J = 6.5, 6.5, 4.0 Hz, 2H), 5.58
(s, 1H), 3.84 (s, 3H), 3.44 (s, 3H), 2.57–2.44 (m, 1H), 2.39–2.16 (m, 4H),
2.14–2.01 (m, 1H). 13C NMR (75 MHz, δ ppm/CDCl3): 209.9 (C), 170.3
(C), 158.1 (C), 134.1 (C), 133.9 (C), 130.5 (CH), 128.4 (CH), 126.5 (CH),
126.1 (CH), 68.1 (CH), 61.8 (C), 54.1 (CH3), 38.9 (CH2), 35.8 (CH2), 33.8
(CH3), 20.1 (CH2), 19.5 (CH3).
Carbamate 7hBn: Following the general procedure with 2h
(690 mg, 2.87 mmol), benzylchloroformate (490 µL, 3.45 mmol) and
a 2 M solution of Na2CO3 (2.9 mL, 5.8 mmol) in 28 mL of THF for
4 h, and using EtOAc/PE, 4:6 as eluent for the flash chromatography,
7hBn was obtained as a colorless oil (858 mg, 80 %). Rf (AcOEt/PE,
4:6) = 0.64. HRMS (ESI+): [M + H]+ calcd. for C19H23N2O6+ 375.1551,
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found 375.1549. 1H NMR (300 MHz, δ ppm/CDCl3): 7.45–7.32 (m,
5H), 5.30 (d, J = 12.1 Hz, 1H), 5.20 (d, J = 12.1 Hz, 1H), 4.81 (s, 1H),
4.18 (dq, J = 11.8, 7.1 Hz, 2H), 3.30 (s, 3H), 2.51–2.27 (m, 3H), 2.23–
2.13 (m, 1H), 2.10–1.93 (m, 2H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR
(101 MHz, δ ppm/CDCl3): 211.1 (C), 170.5 (C), 167.1 (C), 156.7 (C),
135.0 (C), 128.9 (CH), 128.9 (2CH), 128.4 (2CH), 69.2 (CH2), 67.9 (CH),
62.2 (CH2), 60.9 (C), 38.7 (CH2), 34.7(CH3), 34.7 (CH2), 20.0 (CH2), 14.0
(CH3). The structure of 7hBn was further ascertained by an HSQC
2D NMR experiment.
Carbamate 7iBn: Following the general procedure with 2i
(1580 mg, 5.23 mmol), benzylchloroformate (890 µL, 6.27 mmol)
and a 2 M solution of Na2CO3 (6.5 mL, 13.0 mmol) in 130 mL of
THF for 4 h, and using EtOAc/PE, 2:8 as eluent for the flash chroma-
tography, 7iBn was obtained as a colorless oil (1180 mg, 52 %).
Rf (AcOEt/PE, 2:8) = 0.30. HRMS (ESI+): [M+H]+ calcd. for C24H25N2O6+
437.1707, found 437.1709; [M+NH4]+ calcd. for C24H28N3O6+
454.1973, found 454.1978. 1H NMR (300 MHz, δ ppm/CDCl3): 7.43–
7.31 (m, 10H), 5.29 (d, J = 11.9 Hz, 1H), 5.18 (d, J = 12.3 Hz, 2H),
5.06 (d, J = 11.9 Hz, 1H), 4.85 (s, 1H), 3.24 (s, 3H), 2.50–2.24 (m, 3H),
2.23–1.88 (m, 3H). 13C NMR (75 MHz, δ ppm/CDCl3): 211.2 (C), 170.4
(C), 167.0 (C), 156.9 (C), 135.0 (C), 134.8 (C), 129.0 (CH), 129.0 (2CH),
128.9 (2CH), 128.8 (CH), 128.8 (2CH), 128.5 (2CH), 69.3 (CH2), 68.2
(CH2), 68.0 (CH), 61.0 (C), 38.7 (CH2), 34.8 (CH2), 34.7 (CH3), 20.0
(CH2).
Carbamate 7jBn: Following the general procedure with 2j (600 mg,
2.32 mmol), benzylchloroformate (660 µL, 4.65 mmol) and a 2 M
solution of Na2CO3 (2.9 mL, 5.8 mmol) in 20 mL of THF for 4 h, and
using EtOAc/PE, 2:8 as eluent for the flash chromatography, 7jBn
was obtained as a yellowish solid (711 mg, 78 %). Rf (AcOEt/PE,
2:8) = 0.28. HRMS (ESI+): [M+H]+ calcd. for C23H25N2O4+ 393.1809,
found 393.1809. 1H NMR (300 MHz, δ ppm/CDCl3): 7.43–7.09 (m,
10H), 5.17–5.08 (m, 2H), 4.60 (dd, J = 7.0, 7.0 Hz, 1H), 3.27 (s, 3H),
3.07–2.87 (m, 2H), 2.42–1.88 (m, 5H), 1.83–1.68 (m, 1H). 13C NMR
(75 MHz, δ ppm/CDCl3): 212.7 (C), 170.9 (C), 157.95 (C), 136.79 (C),
135.26 (C), 129.8 (2CH), 128.8 (2CH), 128.7(CH), 128.5 (2CH), 128.2
(2CH), 126.9 (CH), 69.0 (CH), 68.7 (CH2), 61.3 (C), 39.3 (CH2), 36.7
(CH2), 34.5 (CH2), 34.1 (CH3), 20.0 (CH2).
General Procedure for Triflyl Enol Ethers 8: To a solution of ket-
one 7 (1 equiv.) and Tf2NPh (1.2 equiv.) in anhydrous THF (ca. 0.1 M)
at –80 °C was added a 0.5 M solution of KHMDS in toluene
(1.5 equiv.). The solution was stirred at this temperature during 1 h
then warmed to room temperature and stirred for an additional 2 h
at this temperature. The resulting mixture was poured into a satu-
rated solution of ammonium chloride and extracted with three
times with dichloromethane. The organic layers were combined,
dried with anhydrous sodium sulfate and concentrated in vacuo to
give the crude product, which was purified by flash chromatogra-
phy.
Triflyl Enol Ether 8aMe: Following the general procedure with 7aMe
(456 mg, 1.51 mmol), Tf2NPh (653 mg, 1.83 mmol) and KHMDS 0.5 M
in toluene (4.8 mL, 2.4 mmol) in 17 mL of anhydrous THF, and using
EtOAc/PE, 4:6 as eluent for the flash chromatography, 8aMe was
obtained as a white solid (583 mg, 89 %). Rf (EtOAc/PE, 4:6) = 0.50.
Mp 181.2–181.7 °C. HRMS (ESI+): [M+H]+ calcd. for C17H18F3N2O6S+
435.0832, found 435.0832. 1H NMR (300 MHz, δ ppm/CDCl3): 7.40–
7.31 (m, 3H), 7.09 (dd, J = 7.2, 2.5 Hz, 2H), 5.88 (s, 1H), 5.38 (s, 1H),
3.85 (s, 3H), 3.48 (s, 3H), 2.74–2.39 (m, 3H), 2.19 (dd, J = 11.8, 7.1 Hz,
1H). 13C NMR (75 MHz, δ ppm/CDCl3): 169.8 (C), 158.2 (C), 144.9 (C),
135.6 (C), 129.0 (2CH), 128.8 (CH), 126.0 (2CH), 120.0 (CH), 118.1 (q,
J = 323 Hz, CF3), 70.0 (CH), 61.8 (C), 54.2 (CH3), 35.0 (CH2), 33.9 (CH3),
26.4 (CH2). 19F NMR (282 MHz, δ ppm/CDCl3): –74.1 (s, 3F).
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Triflyl Enol Ether 8aBn: Following the general procedure with 7aBn
(800 mg, 2.11 mmol), Tf2NPh (863 mg, 2.42 mmol) and KHMDS 0.5 M
in toluene (6.2 mL, 3.1 mmol) in 21 mL of anhydrous THF, and using
EtOAc/PE, 2:8 as eluent for the flash chromatography, 8aMe was
obtained as a white solid (908 mg, 84 %). Rf (AcOEt/PE, 2:8) = 0.52.
Mp 134.5–136.5 °C. HRMS (ESI+): [M+H]+ calcd. for C23H22F3N2O6S+
511.1145, found 511.1146. 1H NMR (400 MHz, δ ppm/CDCl3): 7.46–
7.30 (m, 8H), 7.12–7.06 (m, 2H), 5.85 (dd, J = 2.6, 2.6 Hz, 1H), 5.37
(s, 1H), 5.32 (d, J = 12.1 Hz, 1H), 5.19 (d, J = 12.2 Hz, 1H), 3.46 (s,
3H), 2.64–2.32 (m, 3H), 2.10–1.96 (m, 1H). 13C NMR (101 MHz, δ
ppm/CDCl3): 169.8 (C), 157.7 (C), 144.8 (C), 135.6 (C), 135.2 (C), 128.9
(2CH), 128.9 (CH), 128.8 (2CH), 128.7 (CH), 128.3 (2CH), 126.0 (2CH),
119.9 (CH), 118.1 (q, J = 321 Hz, CF3), 70.13 (CH), 69.0 (CH2), 61.8
(C), 34.7 (CH2), 34.0 (CH3), 26.2 (CH2). 19F NMR (282 MHz, δ ppm/
CDCl3): –74.08 (s, 3F).
Triflyl Enol Ether 8dMe: Following the general procedure with 7dMe
(541 mg, 1.56 mmol), Tf2NPh (568 mg, 1.59 mmol) and KHMDS 0.5 M
in toluene (4.4 mL, 2.2 mmol) in 16 mL of anhydrous THF, and using
EtOAc/CH2Cl2, 1:9 as eluent for the flash chromatography, 8dMe was
obtained as a white solid (528 mg, 71 %). Rf (EtOAc/CH2Cl2, 3:7) =
0.83. Mp 152.0–154.0 °C. HRMS (ESI+): [M+H]+ calcd. for
C17H17F3N3O8S+ 480.0683, found 480.0682. 1H NMR (400 MHz, δ
ppm/CDCl3): 8.24 (d, J = 8.7 Hz, 2H), 7.29 (d, J = 8.6 Hz, 3H), 5.93 (s,
1H), 5.48 (s, 1H), 3.88 (s, 3H), 3.50 (s, 3H), 2.74–2.47 (m, 3H), 2.27–
2.20 (m, 1H). 13C NMR (101 MHz, δ ppm/CDCl3): 169.0 (C), 158.1 (C),
148.2 (C), 144.2 (C), 142.8 (C), 127.2 (2CH), 124.4 (2CH), 120.8 (CH),
117.9 (q, J = 322 Hz, CF3), 69.3 (CH), 61.8 (C), 54.6 (CH3), 34.9 (CH2),
34.1 (CH3), 26.5 (CH2). 19F NMR (282 MHz, δ ppm/CDCl3): –74.2 (s,
3F).
Triflyl Enol Ether 8fBn: Following the general procedure with 7fBn
(600 mg, 1.47 mmol), Tf2NPh (672 mg, 1.88 mmol) and KHMDS 0.5 M
in toluene (4.4 mL, 2.2 mmol) in 15 mL of anhydrous THF, and using
EtOAc/PE, 2:8 as eluent for the flash chromatography, 8fBn was ob-
tained as a white solid (580 mg, 73 %). Rf (AcOEt/PE, 2:8) = 0.18.
Mp 103.9–105.9 °C. HRMS (ESI+): [M+H]+ calcd. for C24H24F3N2O7S+
541.1251, found 541.1251. 1H NMR (300 MHz, δ ppm/CDCl3): 7.40–
7.30 (m, 5H), 7.01 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 5.84
(dd, J = 2.8, 2.6 Hz, 1H), 5.32 (d, J = 12.2 Hz, 1H), 5.32 (s, 1H), 5.18
(d, J = 12.2 Hz, 1H), 3.79 (s, 3H), 3.44 (s, 3H), 2.64–2.30 (m, 3H), 2.05–
1.95 (m, 1H). 13C NMR (75 MHz, δ ppm/CDCl3): 170.0 (C), 160.2 (C),
157.7 (C), 145.0 (C), 135.3 (C), 128.9 (2CH), 128.9 (CH), 128.4 (2CH),
127.8 (C), 127.3 (2CH), 119.9 (CH), 114.5 (2CH), 69.9 (CH), 69.0 (CH2),
61.8 (C), 55.6 (CH3), 34.7 (CH2), 34.1 (CH3), 26.3 (CH2). Resonance for
CF3 not detected due to a low S/N ratio. 19F NMR (282 MHz, δ ppm/
CDCl3): –74.15 (s, 3F).
Triflyl Enol Ether 8gMe: Following the general procedure with 7gMe
(498 mg, 1.57 mmol), Tf2NPh (675 mg, 1.89 mmol) and KHMDS 0.5 M
in toluene (4.8 mL, 2.4 mmol) in 18 mL of anhydrous THF, and using
EtOAc/PE, 4:6 as eluent for the flash chromatography, 8gMe was
obtained as a white solid (469 mg, 67 %). Rf (EtOAc/PE, 4:6) = 0.83.
Mp 134.0–135.1 °C. HRMS (ESI+): [M+H]+ calcd. for C18H20N2O6SF3+
449.0989, found 449.0990. 1H NMR (400 MHz, δ ppm/CDCl3): 7.24–
7.14 (m, 3H), 7.03–6.99 (m, 1H), 5.83 (dd, J = 2.6, 2.6 Hz, 1H), 5.72
(s, 1H), 3.85 (s, 3H), 3.49 (s, 3H), 2.70–2.56 (m, 2H), 2.55–2.44 (m, 1H),
2.31 (s, 3H), 2.25 (ddd, J = 13.0, 7.4, 1.9 Hz, 1H). 13C NMR (101 MHz,
δ ppm/CDCl3): 169.9 (C), 158.1 (C), 145.2 (C), 134.6 (C), 134.2 (C),
131.0 (CH) 128.7 (CH), 126.8 (CH), 125.4 (CH), 120.2, (CH), 118.1 (q,
J = 322 Hz, CF3), 67.3 (CH), 61.4 (C), 54.2 (CH3), 35.2 (CH2), 33.9 (CH3),
26.7 (CH2), 19.5 (CH3). 19F NMR (282 MHz, δ ppm/CDCl3): –74.0 (s,
3F).
Triflyl Enol Ether 8hBn: Following the general procedure with 7hBn
(820 mg, 2.19 mmol), Tf2NPh (861 mg, 2.40 mmol) and KHMDS 0.5 M
Full Paper
in toluene (6.6 mL, 3.3 mmol) in 22 mL of anhydrous THF, and using
EtOAc/PE, 2:8 as eluent for the flash chromatography, 8hBn was
obtained as a white solid (515 mg, 46 %). Rf (AcOEt/PE, 2:8) = 0.35.
Mp 122.4–122.9 °C. HRMS (ESI+): [M+H]+ calcd. for C20H22F3N2O8S+
507.1043, found 507.1042. 1H NMR (300 MHz, δ ppm/CDCl3): 7.45–
7.32 (m, 5H), 6.02 (dd, J = 2.6, 2.6 Hz, 1H), 5.32 (d, J = 12.0 Hz, 1H),
5.19 (d, J = 12.0 Hz, 1H), 4.90 (s, 1H), 4.30–4.09 (m, 2H), 3.30 (s, 3H),
2.62–2.44 (m, 2H), 2.29 (ddd, J = 13.1, 8.2, 7.0 Hz, 1H), 1.94 (ddd,
J = 13.2, 7.1, 3.2 Hz, 1H), 1.28 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz,
δ ppm/CDCl3): 170.4 (C), 167.1 (C), 156.8 (C), 143.4 (C), 135.0 (C),
129.0 (CH), 128.9 (2CH), 128.6 (2CH), 121.3 (CH), 69.3 (CH2), 67.5
(CH), 62.6 (CH2), 59.8 (C), 34.7 (CH3), 33.5 (CH2), 26.3 (CH2), 13.9
(CH3). Resonance for CF3 not detected due to a low S/N ratio. 19F
NMR (282 MHz, δ ppm/CDCl3): –73.51 (s, 3F).
Triflyl Enol Ether 8iBn: Following the general procedure with 7iBn
(1100 mg, 2.52 mmol), Tf2NPh (1152 mg, 3.22 mmol) and KHMDS
0.5 M in toluene (7.6 mL, 3.8 mmol) in 25 mL of anhydrous THF, and
using EtOAc/PE, 2:8 as eluent for the flash chromatography, 8iBn
was obtained as a white solid (584 mg, 41 %). Rf (AcOEt/PE, 2:8) =
0.40. HRMS (ESI+): [M+H]+ calcd. for C25H24F3N2O8S+ 569.1200,
found 569.1200. 1H NMR (300 MHz, δ ppm/CDCl3): 7.42–7.28 (m,
10H), 6.04 (dd, J = 2.7, 2.7 Hz, 1H), 5.30 (d, J = 12.0 Hz, 1H), 5.21 (d,
J = 8.8 Hz, 1H), 5.18 (d, J = 8.8 Hz, 1H), 5.09 (d, J = 12.0 Hz, 1H),
4.97 (s, 1H), 3.20 (s, 3H), 2.55–2.44 (m, 2H), 2.24–2.36 (m, 1H), 1.95
(ddd, J = 13.4, 6.9, 3.7 Hz, 1H). 13C NMR (75 MHz, δ ppm/CDCl3):
170.3 (C), 166.9 (C), 156.7 (C), 143.4 (C), 135.0 (C), 134.5 (C), 129.0
(CH), 128.9 (2CH), 128.8 (2CH), 128.7 (2CH), 128.5 (2CH), 127.0 (CH),
121.2 (CH), 118.5 (q, J = 322 Hz, CF3), 69.2 (CH2), 68.4 (CH2), 67.5
(CH), 59.9 (C), 34.6 (CH3), 33.4 (CH2), 26.3 (CH2). 19F NMR (282 MHz,
δ ppm/CDCl3): –73.33.
Triflyl Enol Ether 8jBn: Following the general procedure with 7jBn
(709 mg, 1.81 mmol), Tf2NPh (826 mg, 2.31 mmol) and KHMDS 0.5 M
in toluene (5.4 mL, 2.7 mmol) in 25 mL of anhydrous THF, and using
EtOAc/PE, 2:8 as eluent for the flash chromatography, 8jBn was ob-
tained as a white solid (800 mg, 84 %). Rf (EtOAc/PE, 2:8) = 0.49.
HRMS (ESI+): [M+H]+ calcd. for C24H24F3N2O6S+ 525.1302, found
525.1302. Mp 103.3–103.7 °C. 1H NMR (300 MHz, δ ppm/CDCl3):
7.35–7.24 (m, 6H), 7.20–7.15 (m, 2H), 7.08–7.03 (m, 2H) 6.02 (dd, J =
2.5, 2.5 Hz, 1H), 5.06–4.98 (m, 2H), 4.58 (dd, J = 11.7, 3.8 Hz, 1H),
3.30 (s, 3H), 2.91–2.68 (m, 2H), 2.49–2.41 (m, 2H), 2.30–2.17 (m, 1H),
1.86 (ddd, J = 13.1, 6.4, 3.1 Hz, 1H). 13C NMR (75 MHz, δ ppm/
CDCl3): 170.6 (C), 157.7 (C), 145.0 (C), 136.8 (C), 135.1 (C), 129.4
(2CH), 128.7 (2CH), 128.6 (CH), 128.5 (2CH), 128.0 (2CH), 126.9 (CH),
121.3 (CH), 118.5 (q, J = 320 Hz, CF3), 69.3 (CH), 68.6 (CH2), 60.0 (C),
36.6 (CH2), 34.1 (CH3), 33.3 (CH2), 26.2 (CH2). 19F NMR (282 MHz, δ
ppm/CDCl3): –73.7 (s, 3F).
General Procedure for Olefins 9: To a solution of 8 in anhydrous
DMF (ca 0.1 M) under an argon atmosphere was added palladium
diacetate (20–50 mol-%), triphenylphosphane (60–100 mol-%), for-
mic acid (2 equiv.) and tributylamine (3 equiv.). The resulting mix-
ture was heated at 80 °C and stirred at this temperature for 4 h.
After cooling to room temperature, the mixture was diluted with
ethyl acetate, washed twice 1 M HCl and twice with brine. The
organic layer was dried with anhydrous sodium sulfate, filtered and
concentrated in vacuo to afford the crude product, which was puri-
fied by flash chromatography.
Olefin 9hBn: Following the general procedure with 8hBn (400 mg,
0.79 mmol), Pd(OAc)2 (89 mg, 0.40 mmol), PPh3 (207 mg,
0.79 mmol), formic acid (60 µL, 1.59 mmol) and nBu3N (565 µL,
2.38 mmol) in anhydrous DMF (16 mL), and using EtOAc/PE, 2:8 as
eluent for the flash chromatography, 9hBn was obtained as a color-
less oil (161 mg, 57 %). Rf (EtOAc/PE, 2:8) = 0.27. HRMS (ESI+):
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[M+H]+ calcd. for C19H23N2O5+ 359.1601, found 359.1604. 1H NMR
(300 MHz, δ ppm/CDCl3): 7.47–7.30 (m, 5H), 6.19–6.13 (m, 1H), 5.34–
5.28 (m, 1H), 5.30 (d, J = 12.1 Hz, 1H), 5.20 (d, J = 12.1 Hz, 1H), 4.76
(s, 1H), 4.25–4.13 (m, 2H), 3.28 (s, 3H), 2.52–2.42 (m, 2H), 2.20–2.06
(m, 1H), 1.95–1.84 (m, 1H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz,
δ ppm/CDCl3): 175.1 (C), 168.1 (C), 156.9 (C), 139.2 (CH), 135.3 (C),
128.8 (2CH), 128.8 (CH), 128.3 (2CH), 126.5 (CH), 69.2 (CH), 68.9
(CH2), 61.7 (CH2), 60.9 (C), 34.8 (CH3), 34.8 (CH2), 31.8 (CH2), 14.2
(CH3).
Olefin 9iBn: Following the general procedure with 8iBn (584 mg,
1.03 mmol), Pd(OAc)2 (46 mg, 0.20 mmol), PPh3 (162 mg,
0.62 mmol), formic acid (77 µL, 2.04 mmol) and nBu3N (734 µL,
3.09 mmol) in anhydrous DMF (10 mL), and using EtOAc/PE, 2:8 as
eluent for the flash chromatography, 9iBn was obtained as a yellow-
ish oil (332 mg, 77 %). Rf (AcOEt/PE, 3:7) = 0.64. HRMS (ESI+): [M+H]+
calcd. for C24H25N2O5+ 421.1758, found 421.1758. 1H NMR (300 MHz,
δ ppm/CDCl3): 7.42–7.26 (m, 10H), 6.09 (ddd, J = 5.8, 2.4, 2.4 Hz,
1H), 5.30 (d, J = 12.0 Hz, 1H), 5.23–5.09 (m, 4H), 4.82 (s, 1H), 3.23 (s,
3H), 2.45 (dddd, J = 7.1, 4.6, 2.4, 2.4 Hz, 2H), 2.12 (ddd, J = 13.1, 8.6,
7.1 Hz, 1H), 1.89 (ddd, J = 13.2, 6.7, 4.6 Hz, 1H). 13C NMR (75 MHz,
δ ppm/CDCl3): 174.9 (C), 168.0 (C), 156.8 (C), 139.3 (CH), 135.3 (C),
134.8 (C), 128.9 (2CH), 128.8 (2CH), 128.8 (CH), 128.7 (2CH), 128.7
(CH), 128.4 (2CH), 126.5 (CH), 69.1 (CH), 69.0 (CH2), 67.5 (CH2), 61.0
(C), 34.8 (CH2), 34.8 (CH3), 31.8 (CH2).
Olefin 9jBn: Following the general procedure with 8jBn (597 mg,
1.14 mmol), Pd(OAc)2 (51 mg, 0.23 mmol), PPh3 (179 mg,
0.68 mmol), formic acid (81 µL, 2.15 mmol) and nBu3N (860 µL,
3.62 mmol) in anhydrous DMF (23 mL), and using EtOAc/PE, 2:8 as
eluent for the flash chromatography, 9jBn was obtained as a yellow-
ish oil (380 mg, 89 %). Rf (AcOEt/PE, 2:8) = 0.26. HRMS (ESI+): [M+H]+
calcd. for C23H25N2O3+ 377.1860, found 377.1860. 1H NMR (300 MHz,
δ ppm/CDCl3): 7.38–7.30 (m, 3H), 7.30–7.23 (m, 3H), 7.21–7.14 (m,
2H), 7.14–7.07 (m, 2H), 6.23–6.15 (m, 1H), 5.68–5.61 (m, 1H), 5.06
(dd, J = 14.5, 12.7, 3H), 4.46 (dd, J = 11.4, 3.4 Hz, 1H), 3.27 (s, 3H),
2.84 (dd, J = 14.0, 3.5 Hz, 1H), 2.59 (dd, J = 13.8, 11.8 Hz, 1H), 2.51–
2.40 (m, 2H), 2.16–2.01 (m, 1H), 1.94–1.81 (m, 1H). 13C NMR (75 MHz,
δ ppm/CDCl3): 175.5 (C), 158.0 (C), 138.5 (CH), 137.5 (C), 135.5 (C),
129.4 (2CH), 128.6 (2CH), 128.4 (2CH), 128.4 (CH), 127.9 (2CH), 127.1
(CH), 126.7 (CH), 70.6, (CH), 68.2 (CH2), 62.0 (C), 36.8 (CH2), 34.3
(CH2), 33.9 (CH3), 31.7 (CH2).
General Procedure for Tetracyclic Compounds 10: To a solution
of 8 in anhydrous DMF (ca 0.1 M) under an argon atmosphere was
added palladium diacetate (20–50 mol-%), triphenylphosphane (60–
100 mol-%) and tributylamine (3 equiv.). The resulting mixture was
heated at 80 °C and stirred at this temperature for 1–23 h. After
cooling to room temperature, the mixture was diluted with ethyl
acetate, washed twice 1 M HCl and twice with brine. The organic
layer was dried with anhydrous sodium sulfate, filtered and concen-
trated in vacuo to afford the crude product, which was purified by
flash chromatography.
Tetracyclic Compound 10aMe: Following the general procedure
with 8aMe (494 mg, 1.14 mmol), Pd(OAc)2 (128 mg, 0.57 mmol),
PPh3 (298 mg, 1.14 mmol) and nBu3N (810 µL, 3.41 mmol) in anhy-
drous DMF (11 mL) for 1.5 h, and using EtOAc/PE, 4:6 as eluent for
the flash chromatography, 10aMe was obtained as a yellow solid
(321 mg, 99 %). Rf (EtOAc/PE, 4:6) = 0.53. Mp 152.0–154.0 °C. HRMS
(ESI+): [M+H]+ calcd. for C16H17N2O3+ 285.1234, found 285.1235. 1H
NMR (300 MHz, δ ppm/CDCl3): 7.50–7.41 (m, 2H), 7.38–7.26 (m, 2H),
6.14 (dd, J = 3.4, 2.0 Hz, 1H), 5.43 (s, 1H), 3.92 (s, 3H), 3.35–3.21 (m,
1H), 3.10 (s, 3H), 2.73 (ddd, J = 12.4, 8.7, 3.5 Hz, 1H), 2.37 (dd, J =
12.4, 6.5 Hz, 1H), 2.12–2.02 (m, 1H). 13C NMR (75 MHz, δ ppm/
CDCl3): = 173.8 (C), 158.4 (C), 147.0 (C), 146.1 (C), 135.5 (C), 129.6
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(CH), 128.9 (CH), 126.0 (CH), 123.2 (CH), 122.4 (CH), 68.3 (CH), 66.9
(C), 54.0 (CH3), 37.6 (CH2), 34.3 (CH3), 33.2 (CH2).
Tetracyclic Compound 10dMe: Following the general procedure
with 8dMe (425 mg, 0.89 mmol), Pd(OAc)2 (100 mg, 0.45 mmol),
PPh3 (233 mg, 0.89 mmol) and nBu3N (630 µL, 2.65 mmol) in anhy-
drous DMF (9 mL) for 4 h, and using EtOAc/PE, 5:5 as eluent for the
flash chromatography, 10aMe was obtained as a yellow solid
(288 mg, 98 %). Rf (EtOAc/PE, 5:5) = 0.46. Mp 189.0–191.0 °C. HRMS
(ESI+): [M+H]+ calcd. for C16H16N3O5+ 330.1084, found 330.1086. 1H
NMR (300 MHz, δ ppm/CDCl3): 8.25 (d, J = 2.0 Hz, 1H), 8.16 (dd, J =
8.4, 2.2 Hz, 1H), 7.63 (d, J = 8.4 Hz, 1H), 6.35 (dd, J = 3.4, 2.0 Hz,
2H), 5.50 (s, 1H), 3.94 (s, 3H), 3.40–3.26 (m, 1H), 3.11 (s, 3H), 2.80
(ddd, J = 14.9, 8.7, 3.6 Hz, 1H), 2.42 (dd, J = 12.5, 6.5 Hz, 1H), 2.18–
2.08 (m, 1H). 13C NMR (75 MHz, δ ppm/CDCl3): 172.7 (C), 158.3 (C),
152.5 (C), 149.5 (C), 144.9 (C), 136.9 (C), 127.1 (CH), 126.9 (CH), 123.9
(CH), 117.5 (CH), 67.9 (CH), 67.3 (C), 54.3 (CH3), 37.8 (CH2), 34.3 (CH3),
33.4 (CH2).
Tetracyclic Compound 10fBn: Following the general procedure
with 8fBn (550 mg, 1.02 mmol), Pd(OAc)2 (46 mg, 0.20 mmol), PPh3
(160 mg, 0.61 mmol) and nBu3N (727 µL, 3.06 mmol) in anhydrous
DMF (20 mL) for 4 h, and using EtOAc/PE, 5:5 as eluent for the
flash chromatography, 10fBn was obtained as a white solid (388 mg,
98 %). Rf (AcOEt/PE, 2:8) = 0.14. Mp 122.3–124.3 °C. HRMS (ESI+):
[M+H]+ calcd. for C23H23N2O4+ 391.1652, found 391.1654. 1H NMR
(300 MHz, δ ppm/CDCl3): 7.43–7.37 (m, 5H), 7.34 (d, J = 8.4 Hz, 1H),
6.92 (d, J = 2.5 Hz, 1H), 6.84 (dd, J = 8.4, 2.5 Hz, 1H), 6.11 (dd, J =
3.5, 2.0 Hz, 1H), 5.40 (s, 1H), 5.35 (d, J = 12.1 Hz, 1H), 5.29 (d, J =
12.1 Hz, 1H), 3.81 (s, 3H), 3.19–3.33 (m, 1H), 2.71 (ddd, J = 16.6, 8.1,
3.5 Hz, 1H), 2.32 (dd, J = 12.5, 6.6 Hz, 1H), 2.02 (ddd, J = 12.5, 9.4 Hz,
1H). 13C NMR (75 MHz, δ ppm/CDCl3): 173.9 (C), 161.1 (C), 157.7 (C),
147.0 (C), 138.1 (C), 136.8 (C), 135.6 (C), 128.9 (2CH), 128.7 (CH),
128.2 (2CH), 126.8 (CH), 123.1 (CH), 116.3 (CH), 106.3 (CH), 68.7
(CH2), 68.0 (CH), 67.5 (C), 55.7 (CH3), 37.5 (CH2), 34.4 (CH3), 33.0
(CH2).
Tetracyclic Compound 10gMe: Following the general procedure
with 8gMe (400 mg, 0.89 mmol), Pd(OAc)2 (100 mg, 0.44 mmol),
PPh3 (234 mg, 0.89 mmol) and nBu3N (640 µL, 2.69 mmol) in anhy-
drous DMF (9 mL) for 23 h, and using EtOAc/PE, 3:7 as eluent for
the flash chromatography, 10gMe was obtained as a yellow solid
(246 mg, 93 %). Rf (EtOAc/PE, 3:7) = 0.44. Mp 170.0–170.8 °C. HRMS
(ESI+): [M+H]+ calcd. for C17H19N2O3+ 299.1390, found 299.1390. 1H
NMR (400 MHz, δ ppm/CDCl3): 7.28 (d, J = 7.6 Hz, 1H), 7.22 (dd, J =
7.6, 7.3 Hz, 1H), 7.07 (d, J = 7.3 Hz, 1H), 6.09 (dd, J = 3.3, 1.9 Hz,
1H), 5.54 (s, 1H), 3.92 (s, 3H), 3.25 (dddd, J = 16.5, 9.2, 6.6, 2.0 Hz,
1H), 3.10 (s, 3H), 2.71 (ddd, J = 16.5, 8.7, 3.5 Hz, 1H), 2.40 (s, 3H),
2.36 (dd, J = 12.2, 6.6 Hz, 1H), 2.10–2.01 (m, 1H). 13C NMR (101 MHz,
δ ppm/CDCl3): 173.9 (C), 158.8 (C), 147.0 (C), 143.0 (C), 137.3 (C),
135.7 (C), 130.5 (CH), 129.7 (CH), 122.7 (CH), 119.9 (CH), 68.9 (CH),
66.6 (C), 54.0 (CH3), 37.5 (CH2), 34.2 (CH3), 32.9 (CH2), 18.2 (CH3).
Keto Ester 11: To a solution of phenyl 3-oxobutanoate (2.50 g,
13 mmol) in 32 mL of anhydrous DMF was added K2CO3 (3.59 g,
26 mmol), 1,4-dibromobutane (4.7 mL, 39 mmol) and nBu4NI
(480 mg, 1.3 mmol), and the resulting mixture was stirred at room
temperature for 2 days. Brine (30 mL) and ethyl acetate (30 mL)
were added and the organic layer separated. The aqueous layer was
extracted twice with EtOAc and the combined organic layers were
dried with anhydrous Na2SO4, concentrated in vacuo and purified
by flash chromatography eluted with EtOAc/PE, 1:9 to afford 11 as
a colorless oil (1.46 g, 46 %). Rf (ACOEt/PE, 1:9) = 0.40. 1H NMR
(300 MHz, δ ppm/CDCl3): 7.85 (dd, J = 8.3, 1.4 Hz, 2H), 7.55–7.45
(m, 1H), 7.44–7.35 (m, 2H), 4.04 (q, J = 7.1 Hz, 2H), 2.49–2.21 (m,
4H), 1.86–1.60 (m, 4H), 0.96 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz,
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δ ppm/CDCl3): 196.2 (C), 174.8 (C), 135.56 (C), 132.7 (CH), 128.9
(2CH), 128.5 (2CH), 63.8 (C), 61.37 (CH2), 35.2 (2CH2), 26.4 (2CH2),
13.8 (CH3).
Acylhydrazone 12: Keto ester 11 (350 mg, 1.42 mmol) and methyl-
hydrazine (230 µL, 4.39 mmol) were allowed to react neat at room
temperature for 3 days. Purification of the resulting material by flash
chromatography eluted with EtOAc/PE, 2:8 afforded 12 (320 mg,
99 %) as a white solid. Rf (AcOEt/PE, 2:8) = 0.50. Mp 89.8–91.2 °C.
HRMS (ESI+): [M+H]+ calcd. forC14H17N2O+ 229.1335, found
229.1337. 1H NMR (300 MHz, δ ppm/CDCl3): 7.77–7.71 (m, 2H), 7.43–
7.38 (m, 3H), 3.32 (s, 3H), 2.21–1.90 (m, 8H). 13C NMR (75 MHz, δ
ppm/CDCl3): 180.8 (C), 161.3 (C), 130.7 (C), 129.9 (CH), 128.9 (2CH),
126.3 (2CH), 56.9 (C), 36.0 (2CH2), 31.5 (CH3), 27.5 (2CH2).
Spirobicyclic Pyrazolidinone 3b: To a solution of 12 (243 mg,
1.06 mmol) in methanol (18 mL) was added 10 % Pd/C (113 mg)
and the solution was placed under an atmosphere of hydrogen with
vigorous stirring for three days at room temperature. The resulting
suspension was filtered through celite, concentrated in vacuo and
purified by flash chromatography eluted with EtOAc/CH2Cl2, 4:6 to
afford pure 3b (143 mg, 59 %) as a white solid. Rf (AcOEt/CH2Cl2,
4:6) = 0.24. HRMS (ESI+): [M+H]+ calcd. for C14H19N2O+ 231.1492,
found 231.1491. 1H NMR (300 MHz, δ ppm/CDCl3): 7.39–7.29 (m,
3H), 7.23–7.18 (m, 2H), 4.73 (broad s, 1H), 4.31 (s, 1H), 3.15 (s, 3H),
2.17–2.04 (m, 1H), 1.89–1.75 (m, 2H), 1.72–1.55 (m, 3H), 1.42–1.31
(m, 1H), 1.29–1.15 (m, 1H). 13C NMR (75 MHz, δ ppm/CDCl3): 176.5
(C), 138.0 (C), 128.7 (2CH), 128.1 (CH), 127.1 (2CH), 69.1 (CH), 56.2
(C), 35.8 (CH2), 31.8 (CH3), 30.7 (CH2), 25.5 (CH2), 25.5 (CH2).
Spirobicyclic Pyrazolidinone 3h: To a solution of 9hBn (510 mg,
1.42 mmol) in methanol (100 mL) was added 10 % Pd/C (151 mg)
and the solution was placed under an atmosphere of hydrogen with
vigorous stirring for five days at room temperature. The resulting
suspension was filtered through celite, concentrated in vacuo and
purified by flash chromatography eluted with EtOAc/PE, 6:4 to af-
ford pure 3h (250 mg, 78 %) as a colorless oil. Rf (EtOAc/PE, 4:6) =
0.20. HRMS (ESI+): [M+Na]+ calcd. for C11H18N2O3Na+ 249.1210,
found 249.1212. 1H NMR (300 MHz, δ ppm/CDCl3): 4.79 (d, J =
11.1 Hz, 1H), 4.25 (qd, J = 7.3, 1.7 Hz, 2H), 4.03 (d, J = 11.1 Hz, 1H),
3.05 (s, 3H), 2.28–2.15 (m, 1H), 1.89–1.64 (m, 6H), 1.53–1.42 (m, 1H),
1.31 (t, J = 7.3 Hz, 3H). 13C NMR (75 MHz, δ ppm/CDCl3): 175.6 (C),
169.9 (C), 67.2 (CH), 61.7 (CH2), 54.1 (C), 34.9 (CH2), 31.9 (CH2), 31.8
(CH3), 26.4 (CH2), 26.0 (CH2), 14.3 (CH3).
Spirobicyclic Pyrazolidinone 3j: To a solution of 9jBn (310 mg,
0.82 mmol) in methanol (40 mL) was added 10 % Pd/C (88 mg) and
the solution was placed under an atmosphere of hydrogen with
vigorous stirring for three days at room temperature. The resulting
suspension was filtered through celite, concentrated in vacuo and
purified by flash chromatography eluted with EtOAc/PE, 6:4 to af-
ford pure 3h (134 mg, 67 %) as a colorless oil. Rf (AcOEt/PE, 4:6) =
0.10. HRMS (ESI+): [M+H]+ calcd. for C15H21N2O+ 245.1648 found
245.1647. 1H NMR (300 MHz, δ ppm/CDCl3): 7.37–7.22 (m, 5H), 4.14
(broad s, 1H), 3.47 (dd, J = 9.7, 2.5 Hz, 1H), 3.03 (s, 3H), 2.87 (dd, J =
14.0, 2.5 Hz, 1H), 2.67 (dd, J = 14.0, 10.6 Hz, 1H), 2.14–2.01 (m, 1H),
1.98–1.49 (m, 7H). 13C NMR (75 MHz, δ ppm/CDCl3): 177.6 (C), 138.5
(C), 129.1 (2CH), 128.6 (2CH), 126.7 (CH), 66.4 (CH), 54.8 (C), 35.1
(CH2), 34.6 (CH2), 31.8 (CH3), 29.4 (CH2), 26.2 (CH2), 25.6 (CH2).
Tetracyclic Pyrazolidinone 10a: To a solution of 10aMe (162 mg,
0.57 mmol) in anhydrous methanol (6 mL) was added LiOH (14 mg,
0.58 mmol) and the resulting solution was stirred for five days at
room temperature. Brine (10 mL) was then added and the aqueous
layer was extracted three times with dichloromethane. The com-
bined organic layers were dried with anhydrous sodium sulfate, fil-
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tered and concentrated in vacuo to give the crude product, which
was purified by flash chromatography eluted with EtOAc/CH2Cl2,
4:6 to afford pure 10a (47 mg, 39 %) as a yellow solid. Recrystalliza-
tion of this material from dichloromethane gave monocrystalline
prisms suitable for X-ray diffraction analysis.[7] Rf (EtOAc/DCM, 4:6) =
0.15. Mp 217.0–219.0 °C. HRMS (ESI+): [M+H]+ calcd. for C14H15N2O+
227.1179, found 227.1177; [M+Na]+ calcd. for C14H14N2ONa+
249.0998, found 249.0996. 1H NMR (400 MHz, δ ppm/CDCl3): 7.48
(dd, J = 6.6, 2.0 Hz, 1H), 7.43 (dd, J = 6.3, 2.5 Hz, 1H), 7.34–7.27 (m,
2H), 6.11 (dd, J = 3.5, 1.9 Hz, 1H), 4.96 (broad s, 1H), 4.52 (s, 1H),
3.39–3.26 (m, 1H), 2.94 (s, 3H), 2.73 (ddd, J = 16.5, 8.8, 3.5 Hz, 1H),
2.40 (dd, J = 12.2, 6.6 Hz, 2H), 2.05 (dd, J = 12.2, 9.3, 9.3 Hz, 1H).
13C NMR (75 MHz, δ ppm/CDCl3): 173.7 (C), 148.3 (C), 148.2 (C),
135.7 (C), 129.1 (CH), 128.6 (CH), 126.1 (CH), 122.1 (CH), 122.0 (CH),
67.9 (C), 65.4 (CH), 37.5 (CH2), 33.1 (CH2), 31.9 (CH3).
Tetracyclic Pyrazolidinone 1f: To a solution of 10fBn (380 mg,
1.05 mmol) in methanol (49 mL) was added 10 % Pd/C (104 mg)
and the solution was placed under an atmosphere of hydrogen with
vigorous stirring for four days at room temperature. The resulting
suspension was filtered through celite, concentrated in vacuo and
purified by flash chromatography eluted with EtOAc/PE, 6:4 to af-
ford pure 1f (230 mg, 85 %) as a colorless oil. Rf (AcOEt/PE, 4:6) =
0.15. HRMS (ESI+): [M+H]+ calcd. for C15H19N2O2+ 259.1441, found
259.1442. It was not possible to obtain a well-resolved 1H NMR
spectrum at 294 K. It was thus decided to analyze the correspond-
ing trifluoromethanesulfonate salt 1f·TfOH, which was prepared
from a solution of 1f in dichloromethane and 1 equiv. triflic acid
followed by evaporation of volatiles in vacuo. The amorphous solid
obtained was recrystallized from ethyl acetate to give monocrystal-
line prisms suitable for X-ray diffraction analysis.[7] For the trifluoro-
methanesulfonate salt 1f·TfOH: Mp 238–239 °C. 1H NMR (300 MHz,
δ ppm/C6D6): 7.77 (d, J = 8.5 Hz, 1H), 6.78 (dd, J = 8.6, 2.4 Hz, 1H),
6.40 (broad s, 1H), 5.22 (s, 1H), 3.79–3.68 (m, 2H), 3.23 (s, 3H), 3.12
(s, 3H), 2.21–2.09 (m, 1H), 1.88–1.70 (m, 2H), 1.55–1.45 (m, 1H), 1.39–
1.26 (m, 1H), 1.15–0.79 (m, 2H). 13C NMR (75 MHz, δ ppm/CDCl3):
174.1 (C), 163.2 (C), 149.4 (C), 127.3 (CH), 125.6 (C), 115.5 (CH), 109.7
(CH), 71.3 (CH), 61.1 (C), 56.6 (CH), 55.7 (CH3), 36.2 (CH2), 34.3 (CH2),
31.4 (CH3), 26.8 (CH2). Resonance for CF3 not detected due to a low
S/N ratio.
Supporting Information (see footnote on the first page of this
article): Complementary experimental information, details of the
DFT calculations, and copies of spectra and chromatograms.
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